Ashot Gevorkyan, Maxim Ishmuratov, Ilya Lumpov, Samvel Petrosyan, Daniel Sharshunov


One of the main directions of improving medical care was the introduction of inpatient forms of medical care for patients who do not require round-the-clock supervision.

Aim of the research: to prove the effectiveness and economic feasibility of minimally invasive procedures in outpatient conditions.

Materials and methods. The study included 3524 patients in the period from 2010 to 2017, who underwent transrectal prostate biopsy on the basis of the Department of urology of polyclinic No. 195 of the Western district of Moscow. For comparison, the patients were taken, who underwent a biopsy of the prostate gland at the base hospital No. 31, No. 51, No. 17.

Results. The average number of biopsies performed in hospital No. 31, No. 51 and No. 17 for the year amounted to 344 biopsies, and the average detectability of prostate cancer was 142 (41.3 %). The average number of biopsies per year in the urology department of the branch number 2 GP No. 195 amounted to 440.5, and the average detectability of prostate cancer – 152.8 (34.7 %). Thus, with comparable inpatient detection of prostate cancer in one large outpatient urology center, an average of 28 % more biopsies are performed (440.5 versus 344) than in 3 hospitals over a comparable period of time.

Conclusions. Inpatient technologies can reduce the burden on hospitals. The development of hospital-replacing forms is determined by the need of the population and for efficient use of financial and technical resources of health care.


inpatient technologies; prostate biopsy; day hospital; prostate cancer

Full Text:



The health care development strategy of the Russian Federation for the long-term period 2015–2030 (2014). Federal Law 28.06.2014 No. 172-FZ. On Strategic Planning in the Russian Federation.

Safonicheva, O. G., Martynchik, S. A. (2015). The objectives of the development of the scientific platform of medical science "preventive environment": technological solutions. Successes of modern science, 3, 102–106.

Seisen, T., Rouprêt, M., Faix, A. (2012). The prostate gland: a crossroad between the urinary and the seminal tracts. Prog Urol, 22, 2–6. doi:

Vinjamoori, A. H., Jagannathan, J. P., Shinagare, A. B., Taplin, M.-E., Oh, W. K., Van den Abbeele, A. D., Ramaiya, N. H. (2012). Atypical Metastases From Prostate Cancer: 10-Year Experience at a Single Institution. American Journal of Roentgenology, 199 (2), 367–372. doi:

Talaiezadeh, A., Tabesh, H., Sattari, A., Ebrahimi, S. (2013). Cancer Incidence in Southwest of Iran: First Report from Khuzestan Population-Based Cancer Registry, 2002–2009. Asian Pacific Journal of Cancer Prevention, 14 (12), 7517–7522. doi:

Freedman, M. L., Haiman, C. A., Patterson, N., McDonald, G. J., Tandon, A., Waliszewska, A. et. al. (2006). Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proceedings of the National Academy of Sciences, 103 (38), 14068–14073. doi:

Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Thun, M. J. (2008). Cancer Statistics, 2008. CA: A Cancer Journal for Clinicians, 58 (2), 71–96. doi:

Arnold, M., Karim-Kos, H. E., Coebergh, J. W., Byrnes, G., Antilla, A., Ferlay, J. et. al. (2015). Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. European Journal of Cancer, 51 (9), 1164–1187. doi:

Nosov, D. A., Vorobyev, N. A., Gladkov, O. A., Koroleva, I. A., Matveev, V. B., Rusakov, I. G. (2016). Practical recommendations for the medicinal treatment of prostate cancer. Malignant tumors, 4 (2), 343–352.

Chissov, V. I., Rusakov, I. G. (2011). The incidence of prostate cancer in the Russian Federation. Experimental and clinical urology, 2-3, 6–7.

Kaprin, A. D., Starinskij, V. V., Petrova, G. V. (2013). The state of cancer care in Russia in 2012. Moscow, 231.

Daniyal, M., Siddiqui, Z. A., Akram, M., Asif, H. M., Sultana, S., Khan, A. (2014). Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer. Asian Pacific Journal of Cancer Prevention, 15 (22), 9575–9578. doi:

Pushkar, D. Yu., Rasner, P. I., Kupriyanov, Yu. A., Malcev, E. G., Gurov, E. Yu., Umyarov, M. S., Sidorenkov, A. V. (2014). Prostate cancer. Russian medical journal, 17, 5.

Zheng, X.-Y., Zhang, P., Xie, L.-P., You, Q.-H., Cai, B.-S., Qin, J. (2012). Prostate-specific Antigen Velocity (PSAV) and PSAV per Initial Volume (PSAVD) for Early Detection of Prostate Cancer in Chinese Men. Asian Pacific Journal of Cancer Prevention, 13 (11), 5529–5533. doi:

Rogatsch, H., Moser, P., Volgger, H., Horninger, W., Bartsch, G., Mikuz, G., Mairinger, T. (2000). Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens. Human Pathology, 31 (9), 1102–1107. doi:

Prilepskaya, E. A., Kovylina, M. V., Govorov, A. V., Vasilyev, A. O., Sadchenko, A. V., Pushkar, D. Yu. (2016). Histological features of prostate cancer. Experimental and clinical urology, 4, 56–58.

Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V. et. al. (2009). Screening and Prostate-Cancer Mortality in a Randomized European Study. New England Journal of Medicine, 360 (13), 1320–1328. doi:

Zhane, A. K. (2000). Ways to improve inpatient care during the period of health care reform. Saint Petersburg, 23.

Pavlov, Yu. V. (2002). Medical and organizational bases of improvement of work of hospitals of intensive treatment in the conditions of reforming of inpatient care. Saint Petersburg, 40.



  • There are currently no refbacks.

Copyright (c) 2019 Ashot Gevorkyan, Maxim Ishmuratov, Ilya Lumpov, Samvel Petrosyan, Daniel Sharshunov

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)